We've found
					184,457 				
					clinical trials				
				
			
		
							
  	
	Aortic Stenosis Clinical Trial
	PERIGON Pivotal Trial
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Erdheim-Chester Disease Clinical Trial
	Long-term Outcome After Vemurafenib / BRAF Inhibitors Interruption in Erdheim-chester Disease
		Status: Enrolling
  
							
  	
	Erdheim-Chester Disease Clinical Trial
	Long-term Outcome After Vemurafenib / BRAF Inhibitors Interruption in Erdheim-chester Disease
		Status: Enrolling	
	
	
			Updated: 8/10/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Congenital Disorders of Glycosylation Clinical Trial
	Clinical and Basic Investigations Into Known and Suspected Congenital Disorders of Glycosylation
		Status: Enrolling,
							Phase
  
							
  	
	Congenital Disorders of Glycosylation Clinical Trial
	Clinical and Basic Investigations Into Known and Suspected Congenital Disorders of Glycosylation
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Degenerative Lesion of Articular Cartilage of Knee Clinical Trial
	Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
		Status: Enrolling
  
							
  	
	Degenerative Lesion of Articular Cartilage of Knee Clinical Trial
	Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Healthy Clinical Trial
	Evaluation of an Oral Nutritional Supplement on Lean Body Mass in Healthy Older Subjects.
		Status: Enrolling
  
							
  	
	Healthy Clinical Trial
	Evaluation of an Oral Nutritional Supplement on Lean Body Mass in Healthy Older Subjects.
		Status: Enrolling	
	
	
			Updated: 10/26/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Volunteers Clinical Trial
	Screening Protocol to Evaluate Volunteers for NIA Approved Studies
		Status: Enrolling,
							Phase
  
							
  	
	Volunteers Clinical Trial
	Screening Protocol to Evaluate Volunteers for NIA Approved Studies
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
	A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
		Status: Enrolling,
							Phase
													 I
  
							
  	
	Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
	A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
	A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
		Status: Enrolling,
							Phase
													 I
  
							
  	
	Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
	A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
	A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
		Status: Enrolling,
							Phase
													 I
  
							
  	
	Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
	A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
	A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
		Status: Enrolling,
							Phase
													 I
  
							
  	
	Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
	A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
	A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
		Status: Enrolling,
							Phase
													 I
  
							
  	
	Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
	A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
	A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
		Status: Enrolling,
							Phase
													 I
  
							
  	
	Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
	A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Malignant Pleural Effusions Clinical Trial
	Biomarker Levels During Indwelling Pleural cAtheter Sample Testing
		Status: Enrolling,
							Phase
  
							
  	
	Malignant Pleural Effusions Clinical Trial
	Biomarker Levels During Indwelling Pleural cAtheter Sample Testing
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Hematology, Oncology Clinical Trial
	Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Hematology, Oncology Clinical Trial
	Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Hematology, Oncology Clinical Trial
	Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Hematology, Oncology Clinical Trial
	Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Arthritis, Rheumatoid Clinical Trial
	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Septicemia Clinical Trial
	Study to Evaluate the Effectiveness of the Initial Specimen Diversion Device When Collected Through Peripheral Intravenous Catheters
		Status: Enrolling
  
							
  	
	Septicemia Clinical Trial
	Study to Evaluate the Effectiveness of the Initial Specimen Diversion Device When Collected Through Peripheral Intravenous Catheters
		Status: Enrolling	
	
	
			Updated: 4/12/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Blood Transfusion Complications Clinical Trial
	Point-of-Care RBC Washing to Prevent Transfusion-Related Pulmonary Complications
		Status: Enrolling,
							Phase
																				 I,  II
  
							
  	
	Blood Transfusion Complications Clinical Trial
	Point-of-Care RBC Washing to Prevent Transfusion-Related Pulmonary Complications
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
		Status: Enrolling,
							Phase
																				 I,  II
  
							
  	
	Oncology Clinical Trial
	Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
		Status: Enrolling,
							Phase
																				 I,  II
  
							
  	
	Oncology Clinical Trial
	Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
		Status: Enrolling,
							Phase
																				 I,  II
  
							
  	
	Oncology Clinical Trial
	Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Healthy Clinical Trial
	Lipidomics Screening of Anti-inflammatory Drugs and Drug Candidates in Vitro - Part A
		Status: Enrolling,
							Phase
  
							
  	
	Healthy Clinical Trial
	Lipidomics Screening of Anti-inflammatory Drugs and Drug Candidates in Vitro - Part A
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Click here to add this to my saved trials
  
							
  
  
  
  
			Click here to add this to my saved trials
	    
	 Gastroenterology, Nephrology / Urology Clinical Trial
	OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Gastroenterology, Nephrology / Urology Clinical Trial
	OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Stroke Clinical Trial
	Stroke Rehabilitation Using BCI Technology
		Status: Enrolling,
							Phase
													 I
  
							
  	
	Stroke Clinical Trial
	Stroke Rehabilitation Using BCI Technology
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Hypertension Clinical Trial
	Chlorthalidone and HCTZ Impacts on Platelet Activation
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Hypertension Clinical Trial
	Chlorthalidone and HCTZ Impacts on Platelet Activation
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/10/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 10/7/2017	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 10/7/2017	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 10/7/2017	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology Clinical Trial
	Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Uterine Fibroids Clinical Trial
	Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry
		Status: Enrolling,
							Phase
  
							
  	
	Uterine Fibroids Clinical Trial
	Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
	Exhaled NO as a Biomarker of Gestational OSA and Persistence Postpartum
		Status: Enrolling
  
							
  	
	Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
	Exhaled NO as a Biomarker of Gestational OSA and Persistence Postpartum
		Status: Enrolling	
	
	
			Updated: 12/10/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Carcinoma, Squamous Cell of Head and Neck Clinical Trial
	PD 0332991 and Cetuximab in Patients With Incurable SCCHN
		Status: Enrolling,
							Phase
																				 I,  II
  
							
  	
	Carcinoma, Squamous Cell of Head and Neck Clinical Trial
	PD 0332991 and Cetuximab in Patients With Incurable SCCHN
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology, Other Clinical Trial
	Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Other Clinical Trial
	Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Oncology, Other Clinical Trial
	Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
		Status: Enrolling,
							Phase
													 I
  
							
  	
	Oncology Clinical Trial
	Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Gastroenterology, Hematology, Oncology, Rheumatology Clinical Trial
	Wild-type Reovirus in Combination With Carfilzomib and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
		Status: Enrolling,
							Phase
													 I
  
							
  	
	Gastroenterology, Hematology, Oncology, Rheumatology Clinical Trial
	Wild-type Reovirus in Combination With Carfilzomib and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Insulin Resistance Clinical Trial
	Pilot Study to Test Dietary Fat Delivery
		Status: Enrolling
  
							
  	
	Insulin Resistance Clinical Trial
	Pilot Study to Test Dietary Fat Delivery
		Status: Enrolling	
	
	
			Updated: 12/2/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Psychiatry / Psychology Clinical Trial
	Probing the Cannabinoid System in Individuals With a Family History of Psychosis
		Status: Enrolling
  
							
  	
	Psychiatry / Psychology Clinical Trial
	Probing the Cannabinoid System in Individuals With a Family History of Psychosis
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 
  
						
				
			
We've found
					184,457 
				
					clinical trials
				
				
				
	Aortic Stenosis Clinical Trial
	
Updated: 12/31/1969
  
  
  PERIGON Pivotal Trial
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Erdheim-Chester Disease Clinical Trial
	
Updated: 8/10/2016
  
  
  Long-term Outcome After Vemurafenib / BRAF Inhibitors Interruption in Erdheim-chester Disease
		Status: Enrolling	
	Updated: 8/10/2016
Click here to add this to my saved trials
	    
	 
  	
	Congenital Disorders of Glycosylation Clinical Trial
	
Updated: 12/31/1969
  
  
  Clinical and Basic Investigations Into Known and Suspected Congenital Disorders of Glycosylation
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Degenerative Lesion of Articular Cartilage of Knee Clinical Trial
	
Updated: 12/31/1969
  
  
  Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Healthy Clinical Trial
	
Updated: 10/26/2015
  
  
  Evaluation of an Oral Nutritional Supplement on Lean Body Mass in Healthy Older Subjects.
		Status: Enrolling	
	Updated: 10/26/2015
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Volunteers Clinical Trial
	
Updated: 12/31/1969
  
  
  Screening Protocol to Evaluate Volunteers for NIA Approved Studies
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Malignant Pleural Effusions Clinical Trial
	
Updated: 12/31/1969
  
  
  Biomarker Levels During Indwelling Pleural cAtheter Sample Testing
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Hematology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Hematology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Arthritis, Rheumatoid Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Arthritis, Rheumatoid Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Arthritis, Rheumatoid Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Arthritis, Rheumatoid Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Arthritis, Rheumatoid Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Arthritis, Rheumatoid Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Arthritis, Rheumatoid Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Arthritis, Rheumatoid Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Arthritis, Rheumatoid Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Arthritis, Rheumatoid Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Arthritis, Rheumatoid Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Arthritis, Rheumatoid Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Arthritis, Rheumatoid Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Arthritis, Rheumatoid Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Arthritis, Rheumatoid Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Arthritis, Rheumatoid Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Arthritis, Rheumatoid Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Arthritis, Rheumatoid Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Arthritis, Rheumatoid Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Arthritis, Rheumatoid Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Arthritis, Rheumatoid Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Arthritis, Rheumatoid Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Arthritis, Rheumatoid Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Septicemia Clinical Trial
	
Updated: 4/12/2015
  
  
  Study to Evaluate the Effectiveness of the Initial Specimen Diversion Device When Collected Through Peripheral Intravenous Catheters
		Status: Enrolling	
	Updated: 4/12/2015
Click here to add this to my saved trials
	    
	 
  	
	Blood Transfusion Complications Clinical Trial
	
Updated: 12/31/1969
  
  
  Point-of-Care RBC Washing to Prevent Transfusion-Related Pulmonary Complications
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Healthy Clinical Trial
	
Updated: 12/31/1969
  
  
  Lipidomics Screening of Anti-inflammatory Drugs and Drug Candidates in Vitro - Part A
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  Click here to add this to my saved trials
	    
	 
  	
	Gastroenterology, Nephrology / Urology Clinical Trial
	
Updated: 12/31/1969
  
  
  OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Stroke Clinical Trial
	
Updated: 12/31/1969
  
  
  Stroke Rehabilitation Using BCI Technology
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Hypertension Clinical Trial
	
Updated: 12/10/2015
  
  
  Chlorthalidone and HCTZ Impacts on Platelet Activation
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/10/2015
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 10/7/2017
  
  
  A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 10/7/2017
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 10/7/2017
  
  
  A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 10/7/2017
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 10/7/2017
  
  
  A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 10/7/2017
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Uterine Fibroids Clinical Trial
	
Updated: 12/31/1969
  
  
  Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
	
Updated: 12/10/2015
  
  
  Exhaled NO as a Biomarker of Gestational OSA and Persistence Postpartum
		Status: Enrolling	
	Updated: 12/10/2015
Click here to add this to my saved trials
	    
	 
  	
	Carcinoma, Squamous Cell of Head and Neck Clinical Trial
	
Updated: 12/31/1969
  
  
  PD 0332991 and Cetuximab in Patients With Incurable SCCHN
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	B Acute Lymphoblastic Leukemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Gastroenterology, Hematology, Oncology, Rheumatology Clinical Trial
	
Updated: 12/31/1969
  
  
  Wild-type Reovirus in Combination With Carfilzomib and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Insulin Resistance Clinical Trial
	
Updated: 12/2/2015
  
  
  Pilot Study to Test Dietary Fat Delivery
		Status: Enrolling	
	Updated: 12/2/2015
Click here to add this to my saved trials
	    
	 
  	
	Psychiatry / Psychology Clinical Trial
	
Updated: 12/31/1969
  
  
  Probing the Cannabinoid System in Individuals With a Family History of Psychosis
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	